BeStock  
Stocks › Chemicals › WLKP

Westlake Chemical WLKP

US equityMarket cap rank #3358Chemicals
$20.72 −$0.27 (-1.29%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $20.72 0.00%
Open$21.00
Prev close$20.99
Day range$20.60 – $21.11
Volume40.9K
Market cap$730.45M
P/E (TTM)12.3
Dividend yield9.10%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership73.2%-1.96 pts vs. prior quarter
Institutions holding63+1 vs. prior quarter
Insider trades (recent)12 buys / 7 sellsNet buying
Short interest0.42% of floatDays to cover 8.6 · as of 30 Oct 2026
Short-sale volume share22.1%5-day average of daily volume

Short-sale volume as % of daily volume

-3%13%28%43%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$153.8K (4 inflow days, 16 outflow days).

Net flow by order size, last 20 sessions

+$11.9KSuper−$165.7KBig−$57.4KMid−$379.6KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 66.5% of shares outstanding.

Largest holders

  • TTWF LP44.04%
  • Invesco Ltd.14.11%
  • Energy Income Partners LLC4.51%
  • Mirae Asset Global Investments Co., Ltd2.04%
  • ClearBridge Investments, LLC1.80%
  • UBS Asset Management1.25%
  • The Goldman Sachs Group, Inc.0.68%
  • Citigroup Inc.0.62%

By investor type

  • Private Company44.40%
  • Mutual Fund26.20%
  • Public Company2.56%
  • Individual/Insider0.81%
  • Hedge Fund0.09%
  • Family Office/Trust0.00%

Reported short interest has risen from 0.34% to 0.42% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Raymond James Financial, Inc. Public Company 2026/Q3 +50,527 0.2%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +34,177 0.1%
Gilman Hill Asset Management, LLC Mutual Fund 2026/Q3 +26,212 0.3%
Osaic Wealth, Inc. Private Company 2026/Q3 +9,447 0.1%
Pathway Financial Advisers, LLC Mutual Fund 2026/Q3 +6,348 0.3%
ClearBridge Investments, LLC Mutual Fund 2026/Q3 +6,000 1.8%
Arrow Investment Advisors, LLC Mutual Fund 2026/Q3 +1,555 0.0%
Mariner, LLC Mutual Fund 2026/Q3 +1,506 0.0%
MGO One Seven LLC Mutual Fund 2026/Q3 +1,160 0.0%
Pekin Hardy Strauss, Inc. Mutual Fund 2026/Q3 +1,022 0.1%
Harbor Capital Advisors, Inc. Mutual Fund 2026/Q3 +555 0.0%
CX Institutional, LLC Family Office/Trust 2026/Q3 +500 0.0%
Harbor Capital Advisors, Inc. Mutual Fund 2026/Q3 +960 0.0%
George Finley Individual/Insider 2026/Q3 +5,005 0.1%
Lisa Friel Individual/Insider 2026/Q3 +2,503 0.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
11 Aug 2026 George Finley Independent Director of Westlake Chemical Partners GP LLC Other Derivative Acquisition +5,044 – –
11 Aug 2026 Randy Woelfel Independent Director of Westlake Chemical Partners GP LLC Other Derivative Acquisition +5,044 – –
11 Aug 2026 Lisa Friel Independent Director of Westlake Chemical Partners GP LLC Other Derivative Acquisition +5,044 – –
5 Aug 2026 George Finley Independent Director of Westlake Chemical Partners GP LLC Derivative Exercise and Retained +5,005 – 36,935
5 Aug 2026 Randy Woelfel Independent Director of Westlake Chemical Partners GP LLC Derivative Exercise and Sale -5,005 $21.35 23,913
5 Aug 2026 Lisa Friel Independent Director of Westlake Chemical Partners GP LLC Derivative Exercise and Sale -2,502 $21.35 9,666
5 Aug 2026 Lisa Friel Independent Director of Westlake Chemical Partners GP LLC Derivative Exercise and Retained +2,503 – 9,666
26 Aug 2025 Jean-Marc Gilson President, CEO & Director of Westlake Chemical Partners GP LLC Private Acquisition +95 $21.25 11,803
6 Aug 2025 George Finley Independent Director of Westlake Chemical Partners GP LLC Derivative Exercise and Retained +4,882 – 31,930
6 Aug 2025 Randy Woelfel Independent Director of Westlake Chemical Partners GP LLC Derivative Exercise and Sale -4,882 $21.96 23,913
6 Aug 2025 Lisa Friel Independent Director of Westlake Chemical Partners GP LLC Derivative Exercise and Sale -2,441 $21.96 7,163
6 Aug 2025 Lisa Friel Independent Director of Westlake Chemical Partners GP LLC Derivative Exercise and Retained +2,441 – 7,163
5 Aug 2025 George Finley Independent Director of Westlake Chemical Partners GP LLC Other Derivative Acquisition +5,005 – –
5 Aug 2025 Randy Woelfel Independent Director of Westlake Chemical Partners GP LLC Other Derivative Acquisition +5,005 – –
5 Aug 2025 Lisa Friel Independent Director of Westlake Chemical Partners GP LLC Other Derivative Acquisition +5,005 – –
28 May 2025 James Chao Senior Chairman of the Board of Westlake Chemical Partners GP LLC Open Market Disposition -3,700 $22.10 –
27 May 2025 James Chao Senior Chairman of the Board of Westlake Chemical Partners GP LLC Open Market Disposition -10,208 $22.17 3,700
26 May 2025 James Chao Senior Chairman of the Board of Westlake Chemical Partners GP LLC Intent to Sell (Form 144) -13,908 $22.18 –
24 Feb 2025 Jean-Marc Gilson President, CEO & Director of Westlake Chemical Partners GP LLC Private Acquisition +167 $24.75 11,708

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 148,107 0.4% 8.6
15 Oct 2026 143,905 0.4% 5.9
30 Sep 2026 138,343 0.4% 6.9
15 Sep 2026 133,662 0.4% 6.2
31 Aug 2026 134,745 0.4% 5.1
14 Aug 2026 120,891 0.3% 2.4

Discussion

No comments yet — be the first to weigh in on WLKP.

Sign in to join the discussion.

Scroll to Top